Both in Biotechnology
aTyr Pharma vs Pluri
Over the past year ATYR returned −81.9% and PLUR returned −65.8%; their daily moves had a correlation of 0.06.
ATYR −81.9% PLUR −65.8%Growth of $1, one year, split-adjusted
| Metric | ATYR | PLUR |
|---|---|---|
| Price | $5.97 | $1.21 |
| Market cap | $14.9M | $16.4M |
| Today | −3.40% | −1.63% |
| 1 month | −46.4% | +16.3% |
| 6 months | −83.8% | −63.8% |
| Year to date | −80.9% | −59.5% |
| 1 year | −81.9% | — |
| Revenue growth (YoY) | — | −15.8% |
| Gross margin | — | 58.5% |
| Net margin | — | −1755.2% |
| P/E (TTM) | — | — |
| Price / sales | 78.6× | 16.1× |
| Net cash | $56.9M | -$23.9M |
| Dividend yield | — | — |
| Volatility (60d) | 1,072.3% | 80.1% |
| Short % of float | 10.5% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).